Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)

NCT03894228 is registered in ClinicalTrials.gov with Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa as lead sponsor.

NCT NCT03894228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
Lead sponsor
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Phase
Observational
Overall status
Recruiting
Start date
May 21, 2019
Completion date
March 1, 2028
Enrollment
1,750 (estimated)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel diseases, pregnancy